Complexity of receptor tyrosine kinase signal processing

Cold Spring Harbor Perspectives in Biology

Volumn 5, Issue 8, 2013, Pages

  Volinsky, Natalia ^a   Kholodenko, Boris N ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

BIOLOGICAL MODEL; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; REVIEW;

FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE REGULATORY NETWORKS; MODELS, BIOLOGICAL; RECEPTOR CROSS-TALK; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84881046240     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a009043     Document Type: Article

References (113)

1. Aceto N, Sausgruber N, Brinkhaus H, Gaidatzis D, Martiny-Baron G, Mazzarol G, Confalonieri S, Quarto M, Hu G, Balwierz PJ, et al. 2012. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat Med 18: 529-537.
2. Ahmad T, Farnie G, Bundred NJ, Anderson NG. 2004. The mitogenic action ofinsulin-like growth factor Iin normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase. J Biol Chem 279: 1713-1719.
3. Alam-Nazki A, Krishnan J. 2012. An investigation of spatial signal transduction in cellular networks. BMC Syst Biol 6: 83.
4. Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F, Tarcic G, Siwak D, Lahad J, Jacob-Hirsch J, et al. 2007. A module of negative feedback regulators defines growth factor signaling. Nat Genet 39: 503-512.
5. Avraham R, Yarden Y. 2011. Feedback regulation of EGFR signalling: Decision making by early and delayed loops. Nat Rev Mol Cell Biol 12: 104-117.
6. Avraham R, Yarden Y. 2012. Regulation of signalling by mi-croRNAs. Biochem Soc Trans 40: 26-30.
7. Balana ME, Labriola L, Salatino M, Movsichoff F, Peters G, Charreau EH, Elizalde PV. 2001. Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells. Oncogene 20: 34-47.
8. Birtwistle MR, Rauch J, Kiyatkin A, Aksamitiene E, Do-brzynski M, Hoek JB, Kolch W, Ogunnaike BA, Kholo-denko BN. 2012. Emergence of bimodal cell population responses from the interplay between analog single-cell signaling and protein expression noise. BMC Syst Biol 6: 109.
9. Bluthgen N, Legewie S, Kielbasa SM, Schramme A, Tcher-nitsa O, Keil J, Solf A, Vingron M, Schafer R, Herzel H, et al. 2009. A systems biological approach suggests that transcriptional feedback regulation by dual-specificity phosphatase 6 shapes extracellular signal-related kinase activity in RAS-transformed fibroblasts. FEBS J 276: 1024-1035.
10. Borisov N, Aksamitiene E, Kiyatkin A, Legewie S, Berkhout J, Maiwald T, Kaimachnikov NP, Timmer J, Hoek JB, Kholodenko BN. 2009. Systems-level interactions between insulin-EGF networks amplify mitogenic signaling. Mol Syst Biol 5: 256.
11. Boura-Halfon S, Zick Y. 2009. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296: E581-E591.
12. Brown GC, Kholodenko BN. 1999. Spatial gradients of cellular phospho-proteins. FEBS Lett 457: 452-454.
13. Camps M, Nichols A, Gillieron C, Antonsson B, Muda M, Chabert C, Boschert U, Arkinstall S. 1998. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280: 1262-1265.
14. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, etal. 2009. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci 106: 3384-3389.
15. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin G, Moroni C, Mann M, Karin M. 2001. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107: 451-464.
16. Christy B, Nathans D. 1989. Functional serum response elements upstream of the growth factor-inducible gene zif268. Mol Cell Biol 9: 4889-4895.
17. Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB. 2010. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat Methods 7: 148-155.
18. Dijkmans TF, van Hooijdonk LW, Schouten TG, Kamphorst JT, Fitzsimons CP, Vreugdenhil E. 2009. Identification of new nerve growth factor-responsive immediate-early genes. Brain Res 1249: 19-33.
19. Dong C, Waters SB, Holt KH, Pessin JE. 1996. SOS phos-phorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways. J Biol Chem 271: 6328-6332.
20. Dougherty MK, MullerJ, Ritt DA, Zhou M, Zhou XZ, Cope-land TD, Conrads TP, Veenstra TD, Lu KP, Morrison DK. 2005. Regulation of Raf-1 by direct feedback phosphor-ylation. Mol Cell 17: 215-224.
21. Douville E, Downward J.1997. EGF induced SOS phosphor-ylation in PC12 cells involves P90 RSK-2. Oncogene 15: 373-383.
22. Dutta P, Koch A, Breyer B, Schneider H, Dittrich-Breiholz O, Kracht M, Tamura T. 2011. Identification of novel target genes of nerve growth factor (NGF) in human mastocy-toma cell line (HMC-1 [V560G c-Kit]) by transcriptome analysis. BMC Genomics 12: 196.
23. Edwin F, Anderson K, Ying C, Patel TB. 2009. Intermolec-ular interactions of Sprouty proteins and their implications in development and disease. Mol Pharmacol 76: 679-691.
24. Esposito CL, D'Alessio A, de Franciscis V, Cerchia L. 2008. A cross talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. PLoS ONE 3: e1643.
25. Fafalios A, Ma J, Tan X, Stoops J, Luo J, Defrances MC, Zarnegar R. 2011. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med 17: 1577-1584.
26. Ferrell JE Jr. 1999. Building a cellular switch: More lessons from a good egg. Bioessays 21: 866-870.
27. Goentoro L, Shoval O, Kirschner MW, Alon U. 2009. The incoherent feedforward loop can provide fold-change detection in gene regulation. Mol Cell 36: 894-899.
28. Gotoh N.2009. Feedback inhibitors ofthe epidermal growth factor receptor signaling pathways. Int J Biochem Cell Biol 41: 511-515.
29. Grecco HE, Schmick M, Bastiaens PI. 2011. Signaling from the living plasma membrane. Cell 144: 897-909.
30. Gual P, Le Marchand-Brustel Y, Tanti JF. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87: 99-109.
31. Gujral TS, Karp RL, Finski A, Chan M, Schwartz PE, Mac-beath G, Sorger P. 2012. Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays. Oncogene doi:10.1038/onc.2012.378.
32. Guo A, Villen J, Kornhauser J, Lee KA, Stokes MP, Rikova K, Possemato A, Nardone J, Innocenti G, Wetzel R, et al. 2008. Signaling networks assembled by oncogenic EGFR and c-Met. Proc Natl Acad Sci 105: 692-697.
33. Herrero J, Valencia A, Dopazo J. 2001. A hierarchical unsu-pervised growing neural network for clustering gene expression patterns. Bioinformatics 17: 126-136.
34. Hu H, Goltsov A, Bown JL, Sims AH, Langdon SP, Harrison DJ, Faratian D. 2013. Feedforward and feedback regulation of the MAPK and PI3K oscillatory circuit in breast cancer. Cell Signal 25: 26-32.
35. Hunter T. 2000. Signaling-2000 and beyond. Cell 100: 113-127.
36. Hynes NE, Schlange T. 2006. Targeting ADAMS and ERBBs in lung cancer. Cancer Cell 10: 7-11.
37. Jones HE, Gee JM, Hutcheson IR, Knowlden JM, Barrow D, Nicholson RI. 2006. Growth factor receptor interplay and resistance in cancer. Endocr Relat Cancer 13: S45-S51.
38. Kaimachnikov NP, Kholodenko BN. 2009. Toggle switches, pulses and oscillations are intrinsic properties of the Src activation/deactivation cycle. FEBS J 276: 4102-4118.
39. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ. 1993. Induction of TrkB by retinoic acid mediates biologic re-sponsivenessto BDNF and differentiation of human neu-roblastoma cells. Eukaryotic Signal Transduction Group. Neuron 11: 321-331.
40. Kholodenko BN. 2000. Negative feedback and ultrasensitiv-ity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur J Biochem 267: 1583-1588.
41. Kholodenko BN. 2002. MAP kinase cascade signaling and endocytic trafficking: A marriage of convenience? Trends Cell Biol 12: 173-177.
42. Kholodenko BN. 2006. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 7: 165-176.
43. Kholodenko BN. 2009. Spatially distributed cell signalling. FEBS Lett 583: 4006-4012.
44. Kholodenko BN, Hoek JB, Westerhoff HV, Brown GC. 1997. Quantification of information transfer via cellular signal transduction pathways. FEBS Lett 414: 430-434; erratum, 419: 150.
45. Kholodenko BN, Hancock JF, Kolch W. 2010. Signalling ballet in space and time. Nat Rev Mol Cell Biol 11: 414-426.
46. Kim KH, Sauro HM. 2012. In search of noise-induced bi-modality. BMC Biol 10: 89.
47. Kiyatkin A, Aksamitiene E, Markevich NI, Borisov NM, Hoek JB, Kholodenko BN. 2006. Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops. J Biol Chem 281: 19925-19938.
48. Langlois WJ, Sasaoka T, Saltiel AR, Olefsky JM. 1995. Negative feedback regulation and desensitization of insulin-and epidermal growth factor-stimulated p21ras activation. J Biol Chem 270: 25320-25323.
49. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141: 1117-1134.
50. Li J, Johnson SE. 2006. ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem Biophys Res Commun 345: 1425-1433.
51. Ma W, Trusina A, El-Samad H, Lim WA, Tang C. 2009. Defining network topologies that can achieve biochemical adaptation. Cell 138: 760-773.
52. Maeder CI, Hink MA, Kinkhabwala A, Mayr R, Bastiaens PI, Knop M. 2007. Spatial regulation of Fus3 MAP kinase activity through a reaction-diffusion mechanism in yeast pheromone signalling. Nat Cell Biol 9: 1319-1326.
53. Mangan S, Alon U. 2003. Structure and function of the feedforward loop network motif. Proc Natl Acad Sci 100: 11980-11985.
54. Mangan S, Zaslaver A, Alon U. 2003. The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks. J Mol Biol 334: 197-204.
55. Maretzky T, Evers A, Zhou W, Swendeman SL, Wong PM, Rafii S, Reiss K, Blobel CP. 2011a. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. Nat Commun 2: 229.
56. Maretzky T, Zhou W, Huang XY, Blobel CP. 2011b. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloprotei-nase ADAM17. Oncogene 30: 611-618.
57. Martin B, Brenneman R, Golden E, Walent T, Becker KG, Prabhu VV, Wood W 3rd, Ladenheim B, Cadet JL, Maudsley S. 2009. Growth factor signals in neural cells: Coherent patterns of interaction control multiple levels of molecular and phenotypic responses. J Biol Chem 284: 2493-2511.
58. Mason JM, Morrison DJ, Basson MA, Licht JD. 2006. Sprouty proteins: Multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 16: 45-54.
59. McAdams HH, Arkin A. 1997. Stochastic mechanisms in gene expression. Proc Natl Acad Sci 94: 814-819.
60. Mendelson K, Swendeman S, Saftig P, Blobel CP. 2010. Stimulation of platelet-derived growth factor receptor b (PDGFRb) activates ADAM17 and promotes metallo-proteinase-dependent cross-talk between the PDGFRb and epidermal growth factor receptor (EGFR) signaling pathways. J Biol Chem 285: 25024-25032.
61. Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U. 2002. Network motifs: simple building blocks of complex networks. Science 298: 824-827.
62. Munoz-Garcia J, Kholodenko BN. 2010. Signalling over a distance: Gradient patterns and phosphorylation waves within single cells. Biochem Soc Trans 38: 1235-1241.
63. Munoz-Garcia J, Neufeld Z, Kholodenko BN. 2009. Positional information generated by spatially distributed signaling cascades. PLoS Comput Biol 5: e1000330.
64. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4: 556-564.
65. Murphy LO, MacKeigan JP, Blenis J. 2004. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol 24: 144-153.
66. Murphy T, Hori S, Sewell J, Gnanapragasam VJ. 2010. Expression and functional role of negative signalling regulators in tumour development and progression. Int J Cancer 127: 2491-2499.
67. Nakakuki T, Birtwistle MR, Saeki Y, Yumoto N, Ide K, Na-gashima T, Brusch L, Ogunnaike BA, Okada-Hatakeyama M, Kholodenko BN. 2010. Ligand-specific c-Fos expression emerges from the spatiotemporal control of ErbB network dynamics. Cell 141: 884-896.
68. Nakayama K, Satoh T, Igari A, Kageyama R, Nishida E. 2008. FGF induces oscillations of Hes1 expression and Ras/ ERK activation. Curr Biol 18: R332-334.
69. Orton RJ, Sturm OE, Gormand A, Wolch W, Gilbert DR. 2008. Computational modelling reveals feedback redundancy within the epidermal growth factor receptor/extracellular-signal regulated kinase signalling pathway. IET Syst Biol 2: 173-183.
70. Ostman A, Hellberg C, Bohmer FD. 2006. Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 6: 307-320.
71. Owens DM, Keyse SM. 2007. Differential regulation of MAP kinase signalling by dual-specificity protein phospha-tases. Oncogene 26: 3203-3213.
72. Pawson T, Nash P. 2003. Assembly of cell regulatory systems through protein interaction domains. Science 300: 445-452.
73. Pawson T, Gish GD, Nash P. 2001. SH2 domains, interaction modules and cellular wiring. Trends Cell Biol 11: 504-511.
74. Perlson E, Hanz S, Ben-Yaakov K, Segal-Ruder Y, Seger R, Fainzilber M. 2005. Vimentin-dependent spatial translo-cation of an activated MAP kinase in injured nerve. Neuron 45: 715-726.
75. Perlson E, Michaelevski I, Kowalsman N, Ben-Yaakov K, Shaked M, Seger R, Eisenstein M, Fainzilber M. 2006. Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase. J Mol Biol 364: 938-944.
76. Polo S, Di Fiore PP. 2006. Endocytosis conducts the cell signaling orchestra. Cell 124: 897-900.
77. Pomerening JR, Sontag ED, Ferrell JE. 2003. Building a cell cycle oscillator: Hysteresis and bistability in the activation of Cdc2. Nat Cell Biol 5: 346-351.
78. Rao VH, Kandel A, Lynch D, Pena Z, Marwaha N, Deng C, Watson P, Hansen LA. 2011. A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion. Oncogene 31: 2888-2898.
79. Ridley AJ. 2001. Rho GTPases and cell migration. J Cell Sci 114: 2713-2722.
80. Rivera VM, Sheng M, Greenberg ME. 1990. The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation. Genes Dev 4: 255-268.
81. Santos SD, Verveer PJ, Bastiaens PI. 2007. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 9: 324-330.
82. Sauro HM, Kholodenko BN. 2004. Quantitative analysis of signaling networks. Prog Biophys Mol Biol 86: 5-43.
83. Schlessinger J. 2000. Cell signaling by receptor tyrosine ki-nases. Cell 103: 211-225.
84. Schmalhofer O, Brabletz S, Brabletz T. 2009. E-cadherin, b-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28: 151-166.
85. Schmitz-Peiffer C, Whitehead JP. 2003. IRS-1 regulation in health and disease. IUBMB Life 55: 367-374.
86. Segatto O, Anastasi S, Alema S. 2011. Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors. J Cell Sci 124: 1785-1793.
87. Sevecka M, MacBeath G. 2006. State-based discovery: A multidimensional screen for small-molecule modulators of EGF signaling. Nat Methods 3: 825-831.
88. Sha W, Moore J, Chen K, Lassaletta AD, Yi CS, Tyson JJ, Sible JC. 2003. Hysteresis drives cell-cycle transitions in Xen-opus laevis egg extracts. Proc Natl Acad Sci 100: 975-980.
89. Shankaran H, Ippolito DL, Chrisler WB, Resat H, Bollinger N, Opresko LK, Wiley HS. 2009. Rapid and sustained nuclear-cytoplasmic ERK oscillations induced by epidermal growth factor. Mol Syst Biol 5: 332.
90. Shin SY, Rath O, Choo SM, Fee F, McFerran B, Kolch W, Cho KH. 2009. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway. J Cell Sci 122: 425-435.
91. Shin S, Dimitri CA, Yoon SO, Dowdle W, Blenis J. 2010. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformationvia DEF motif-dependent signaling events. Mol Cell 38: 114-127.
92. Shoval O, Alon U. 2010. SnapShot: Network motifs. Cell 143: 326-e321.
93. Smolen P, Baxter DA, Byrne JH. 2008. Bistable MAP kinase activity: A plausible mechanism contributing to maintenance of late long-term potentiation. Am J Physiol Cell Physiol 294: C503-C515.
94. Sorkin A, von Zastrow M. 2009. Endocytosis and signalling: Intertwining molecular networks. Nat Rev Mol Cell Biol 10: 609-622.
95. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. 2009. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459: 428-432.
96. Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Po-nugoti AH, Wiedemeyer R, Stegh AH, Bradner JE, Ligon KL, Brennan C, et al. 2007. Coactivation of receptor ty-rosine kinases affects the response of tumor cells to targeted therapies. Science 318: 287-290.
97. Sturm OE, Orton R, Grindlay J, Birtwistle M, Vyshemirsky V, Gilbert D, Calder M, Pitt A, Kholodenko B, Kolch W. 2010. The mammalian MAPK/ERK pathway exhibits properties of a negative feedback amplifier. Sci Signal 3: 90.
98. Tanizaki J, Okamoto I, Sakai K, Nakagawa K. 2011. Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with METamplification. Br J Cancer 105: 807-813.
99. Treisman R. 1995. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J 14: 4905-4913.
100. Tsui-Pierchala BA, Milbrandt J, Johnson EM Jr. 2002. NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons. Neuron 33: 261-273.
101. Tsyganov MA, Kolch W, Kholodenko BN. 2012. The topology design principles that determine the spatiotempo-ral dynamics of G-protein cascades. Mol Biosyst 8: 730-743.
102. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R. 2006. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 5: 14.
103. Vartak N, Bastiaens P. 2010. Spatial cycles in G-protein crowd control. EMBO J 29: 2689-2699.
104. Velpula KK, Dasari VR, Asuthkar S, Gorantla B, Tsung AJ. 2012. EGFR and c-Met cross talk in glioblastoma and its regulation by human cord blood stem cells. Transl Oncol 5: 379-392.
105. Von Kriegsheim A, Baiocchi D, Birtwistle M, Sumpton D, Bienvenut W, Morrice N, Yamada K, Lamond A, Kalna G, Orton R, et al. 2009. Cell fate decisions are specified by the dynamic ERK interactome. Nat Cell Biol 11: 1458-1464.
106. Wiley HS. 2003. Trafficking of the ErbB receptors and its influence on signaling. Exp Cell Res 284: 78-88.
107. Xu AM, Huang PH. 2010. Receptor tyrosine kinase coacti-vation networks in cancer. Cancer Res 70: 3857-3860.
108. Yang SH, Sharrocks AD, Whitmarsh AJ. 2013. MAP kinase signalling cascades and transcriptional regulation. Gene 513: 1-13.
109. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, et al. 1999. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401: 173-177.
110. Yeung K, Janosch P, McFerran B, Rose DW, Mischak H, Sedivy JM, Kolch W. 2000. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 20: 3079-3085.
111. Yoon S, Seger R. 2006. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44.
112. Zhou BB, Peyton M, He B, Liu C, Girard L, Caudler E, Lo Y, Baribaud F, Mikami I, Reguart N, et al. 2006. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 10: 39-50.
113. Zwang Y, Yarden Y. 2009. Systems biology of growth factor-induced receptor endocytosis. Traffic 10: 349-363.